Regarding type II IFN, the results of the cross-sectional analysis conducted by Piater and collaborators in 142 infected patients show that in most COVID-19 patients, IFN-γ-mediated biochemical pathways were still strongly activated after 60 days. The gene discussed is IFNG; the disease is COVID-19.